|
Volumn 11, Issue 1, 2007, Pages
|
Development of liver dysfunction under artificial nutrition: A reason to modify nutrition therapy in the intensive care unit?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BILIRUBIN;
BIOLOGICAL MARKER;
INSULIN;
LIPID EMULSION;
LIVER ENZYME;
AGE DISTRIBUTION;
ARTIFICIAL FEEDING;
ARTIFICIAL VENTILATION;
BACTERIAL OVERGROWTH;
BILE ACID METABOLISM;
BILIRUBIN BLOOD LEVEL;
BODY WEIGHT;
CLINICAL TRIAL;
CYTOKINE RELEASE;
DIET THERAPY;
ENDOTOXEMIA;
ENZYME ANALYSIS;
GASTROINTESTINAL DISEASE;
HUMAN;
INSULIN RELEASE;
INTENSIVE CARE;
LIPID COMPOSITION;
LIVER DYSFUNCTION;
LIVER METABOLISM;
NOTE;
NUTRITIONAL REQUIREMENT;
NUTRITIONAL SUPPORT;
PATHOGENESIS;
PREVALENCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
SCORING SYSTEM;
SEX DIFFERENCE;
TOTAL PARENTERAL NUTRITION;
INTENSIVE CARE UNIT;
LIVER DISEASE;
TIME;
HUMANS;
INTENSIVE CARE UNITS;
LIVER DISEASES;
PARENTERAL NUTRITION, TOTAL;
RISK FACTORS;
TIME FACTORS;
|
EID: 34248212703
PISSN: 13648535
EISSN: 1466609X
Source Type: Journal
DOI: 10.1186/cc5679 Document Type: Note |
Times cited : (2)
|
References (9)
|